Albumin reduces blood-brain barrier permeability but does not alter infarct size in a rat model of neonatal stroke (Q31118233)

29 June 2017

title

Albumin reduces blood-brain barrier permeability but does not alter infarct size in a rat model of neonatal stroke (English)

1 reference

29 June 2017

1 reference

Rong Wang

1

1 reference

29 June 2017

Stephen Ashwal

2

1 reference

29 June 2017

Beatriz Tone

3

1 reference

29 June 2017

Hou Rou Tian

4

1 reference

29 June 2017

Jerome Badaut

5

1 reference

29 June 2017

Alison Rasmussen

6

1 reference

29 June 2017

Andre Obenaus

7

1 reference

29 June 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

29 June 2017

1 reference

29 June 2017

volume

62

1 reference

29 June 2017

issue

3

1 reference

29 June 2017

page(s)

261-266

1 reference

Epidemiology of perinatal stroke

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Hemodilution for cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Effects of viscosity and oxygen content on cerebral blood flow in ischemic and normal rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Albumin treatment reduces neurological deficit and protects blood-brain barrier integrity after acute intracortical hematoma in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

The antioxidants of human extracellular fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Systemic fatty acid responses to transient focal cerebral ischemia: influence of neuroprotectant therapy with human albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

21 January 2018

The albumin controversy

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Volume expansion during neonatal intensive care: do we know what we are doing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

A new model of neonatal stroke: reversible middle cerebral artery occlusion in the rat pup.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Serial magnetic resonance imaging in a rat pup filament stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Cortical devascularization: quantitative diffusion weighted magnetic resonance imaging and histological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

The antioxidant action of human extracellular fluids. Effect of human serum and its protein components on the inactivation of alpha 1-antiproteinase by hypochlorous acid and by hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Albumin--an important extracellular antioxidant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

A direct role for serum albumin in the cellular uptake of long-chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Binding of drugs to serum albumin (first of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Blood-brain barrier disruption and exacerbation of ischemic brain edema after restoration of blood flow in experimental focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Brain edema and cerebrovascular permeability during cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Prevention of hypoxic-ischemic damage with dexamethasone is dependent on age and not influenced by fasting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Vulnerability to cerebral hypoxic-ischemic insult in neonatal but not in adult rats is in parallel with disruption of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Transient forebrain ischemia increases the blood-brain barrier permeability for albumin in stroke-prone spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Correlation of cerebral hypoxic-ischemic T2 changes with tissue alterations in water content and protein extravasation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

The ALIAS (ALbumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and progress report

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318123F757

10.1203/PDR.0B013E318123F757

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

29 June 2017

1028226522

0 references

1 reference